CTLA4 and cancer: Cancer immunotherapy represents a major breakthrough in cancer treatment with the emergence of immune-checkpoint inhibitors such as anti- programmed death 1 (PD-1) and anti- cytotoxic T lymphocyte antigen 4 (CTLA4) [1, 2].